JCI - ATR kinase inhibitor AZD6738 potentiates CD8+ T cell–dependent antitumor activity following radiation
Ataxia telangiectasia and Rad3-related inhibitors and cancer therapy: where we stand | Journal of Hematology & Oncology | Full Text
ATR Inhibitor Combinations Begin to Tackle DNA Damage Repair in Solid Tumors
IJMS | Free Full-Text | PARP Inhibition Increases the Reliance on ATR/CHK1 Checkpoint Signaling Leading to Synthetic Lethality—An Alternative Treatment Strategy for Epithelial Ovarian Cancer Cells Independent from HR Effectiveness | HTML
Sequential Administration of XPO1 and ATR Inhibitors Enhances Therapeutic Response in TP53-mutated Colorectal Cancer - ScienceDirect
Ceralasertib (AZD6738) | ≥99%(HPLC) | Selleck | ATM/ATR inhibitor
Frontiers | Targeting DNA Damage Repair for Immune Checkpoint Inhibition: Mechanisms and Potential Clinical Applications | Oncology
Preclinical testing of an ATR inhibitor demonstrates improved response to standard therapies for esophageal cancer - Radiotherapy and Oncology
Clinical trial tests ATR inhibitor in difficult-to-treat cancers | VUMC Reporter | Vanderbilt University
Progress towards a clinically-successful ATR inhibitor for cancer therapy - ScienceDirect
Are ATR Inhibitors The Next Precision Medicine to Improve Cancer Outcomes - CancerConnect
Studies confirm the clinical potential of ATR inhibitors
Combined PARP and ATR inhibition potentiates genome instability and cell death in ATM-deficient cancer cells | Oncogene
ATR inhibitor AZD6738 potentiates anti-proliferation of WEE1 inhibitor... | Download Scientific Diagram
Targeting DNA Damage Response and Replication Stress in Pancreatic Cancer - Gastroenterology
Advanced Prostate Cancer with ATM Loss: PARP and ATR Inhibitors - European Urology
Enrolling Clinical Trials: Combination ATR and PARP Inhibitor (CAPRI) Trial With AZD6738 and Olaparib in Recurrent Ovarian Cancer - Penn Physician VideoLink
Progress towards a clinically-successful ATR inhibitor for cancer therapy - ScienceDirect
Schematic model for how dual inhibition of IGF-1R and ATR leads to... | Download Scientific Diagram
Progress towards a clinically-successful ATR inhibitor for cancer therapy - ScienceDirect
ATR inhibitors currently in adult clinical trials. | Download Scientific Diagram
Phase I Trial of First-in-Class ATR Inhibitor M6620 (VX-970) as Monotherapy or in Combination With Carboplatin in Patients With Advanced Solid Tumors | Journal of Clinical Oncology
Enrolling Clinical Trials: Combination ATR and PARP Inhibitor (CAPRI) Trial With AZD6738 and Olaparib in Recurrent Ovarian Cancer - Penn Medicine
EMD SERONO | ATRi
